Pembuatan Antigen Tumor Rekombinan Indonesia

• 

  Keuntungan Produksi Antigen Tumor Rekombinan

  Ini juga memberi kita kemampuan untuk massa dengan aman-menghasilkan protein ini: karena kita memiliki gennya, secara teoritis kita dapat memasukkannya ke dalam organisme apa pun yang dapat menghasilkan banyak protein untuk penggunaan industri dalam lingkungan yang aman dan teratur. Jika kita mengetahui gen mana yang digunakan, maka kita dapat memastikan bahwa protein tersebut tidak beracun bagi manusia dan juga efektif mengobati kanker.

  
  

• 

  Memanfaatkan Antigen Tumor Rekombinan

  Terapi kanker pendekatan menggunakan antigen tumor rekombinan Salah satu caranya adalah melalui vaksin. Selain itu, vaksin ini dikaitkan dengan penurunan risiko berbagai jenis kanker. Ini dilakukan dengan melatih tubuh Anda sendiri untuk mengenali dan membunuh sel kanker jika sel tersebut memasuki sistem tubuh Anda. Ini seperti melatih pengawal Anda untuk mengidentifikasi sel jahat dan memastikan sel tersebut dihentikan sebelum menyebar lebih jauh.

  
  

• 

  "Teknik Inovatif untuk Merekayasa Antigen Tumor Rekombinan guna Melawan Kanker".

  penulis skenario di Yaohan seperti mereka yang pergi ke sekolah di pagi hari dan menghasilkan protein yang lebih baik. Setiap hari mereka bekerja keras untuk menciptakan teknologi baru yang meningkatkan protein yang melawan kanker. Contohnya termasuk menciptakan protein yang lebih baik untuk melawan kanker untuk kanker tertentu. Dengan begitu, mereka menjadi pembunuh yang lebih kuat dari sebelumnya karena Anda telah melatih mereka untuk hanya menyerang sel-sel tertentu. Mereka dapat mengkodekan protein yang dapat memicu respons imun yang lebih kuat juga. Ini pada dasarnya berarti tubuh harus bekerja lebih keras untuk membunuh kanker apa pun yang ada di tubuh Anda.

  
  

Mengapa memilih Yaohai Recombinant Tumor Antigen Manufacturing?

• Kustomisasi, Efisiensi & Efektivitas Biaya

  Yaohai Bio-Pharma is experienced in the development of microbial-derived biologics. We offer customized RD as well as manufacturing solutions, while making sure that there are no risks. We have worked on diverse modalities such as subunit-based recombinant vaccines, Recombinant Tumor Antigen Manufacturing, cytokines, growth factors, single domain antibodies, enzymes, plasmid DNA, the mRNA, and other. We are experts in a variety of microorganisms, including yeast extracellular and intracellular secretion (yields up to 15g/L) as well as bacteria intracellular soluble and inclusion body (yields as high as 10g/L). We have also developed the BSL-2 fermentation platform to create bacteria-based vaccines. We have a track record of improving production processes, thereby increasing yields and decreasing costs. With a highly efficient technology team, we ensure timely and quality project delivery and bring your products to market faster.

• Rantai Pasokan & Kemampuan Manufaktur yang Kuat

  Yaohai Bio-Pharma, a top 10 producer of Recombinant Tumor Antigen Manufacturing, specializes in microbial fermentation. We have set up a modern facility with advanced facilities as well as robust RD manufacturing capabilities. Five production lines for drug substances complying with GMP standards for microbial purification and ferment along with two automated fill and finish lines for vials as well as cartridges as well as pre-filled needles are readily available. The available fermentation scales range between 100L and 2000L. Vial filling specifications cover 1ml - 25ml. the pre-filled cartridge or syringe filling specifications are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. Our plant produces big molecules that are exported to all over the world.

• Keahlian Profesional & Pengalaman Luas

  Yaohai Bio-Pharma is a leading in microbial biologics CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to manage the health of pets, humans and animals. health. We have modern RD and manufacturing technology platforms that cover the entire process, from microbial strain engineering, cell banking, process and method design to commercial and clinical manufacturing, which ensures the success supply of the most cutting-edge solutions. Through the years we have gained vast expertise in using microbial sources. Over 200 projects were successfully completed. In addition, we support our clients in get through regulations, such as those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. Our expert knowledge and vast experience allow us to quickly respond to market demands and provide Recombinant Tumor Antigen Manufacturing CDMO services.

• Sistem Mutu & Kepatuhan Terhadap Peraturan Global

  Yaohai BioPharma, a top 10 Microbial CDMO, integrates quality and regulatory matters. We have a quality system that is fully compliant with the current GMP standards, as well as international regulations. Our team of regulatory experts has a deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We are able to guarantee traceable production procedures and high-quality products that conform with regulations from the US FDA, Recombinant Tumor Antigen Manufacturing, Australia TGA, and China NMPA. Yaohai BioPharma has successfully passed an on-site audit conducted of the European Union's Qualified Person (QP) for our GMP quality system and production site. We also have been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

Kategori produk terkait

• Manufaktur Plasmid AAV
• Metode Analisis DNA Plasmid
• Pembuatan VLP Bakteriofag AP205
• Pembuatan VLP Bakteriofag Q
• Pembuatan Vaksin VLP Chimeric
• Pembuatan Vaksin VLP Konjugasi
• Pembuatan Vaksin DNA
• Fermentasi E. coli untuk Produksi VLP
• Manufaktur Agonis GLP-1
• Manufaktur Analog GLP-1

Tidak menemukan apa yang Anda cari?
Hubungi konsultan kami untuk lebih banyak produk yang tersedia.